{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:35:09Z","timestamp":1758281709013,"version":"3.44.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Mal de Meleda (MDM) is a rare hereditary skin disorder classified as an autosomal recessive palmoplantar keratoderma, with an estimated prevalence of 1 in 100,000 individuals. It is commonly linked to consanguineous parentage and typically presents during early childhood. The hallmark features of the condition include transient thickening of the palms and soles, skin sclerosis and atrophy, scleroatrophic erythematous lesions, pseudoainhum formation around the digits, and erythema around the mouth. Due to its rarity, many dermatologists may lack clinical familiarity with MDM. Moreover, there is considerable phenotypic similarity between Mal de Meleda and other forms of palmoplantar keratoderma, as well as certain erythrokeratodermas, making clinical differentiation particularly difficult. Therefore, genetic testing to identify causative mutations plays a crucial role in confirming the diagnosis. Genetic alterations in the <jats:italic>SLURP1<\/jats:italic> gene, which encodes the secreted Ly-6\/uPAR-related protein 1, have been identified as key contributors to the development of Mal de Meleda (MDM). SLURP1 plays a critical role in maintaining epidermal equilibrium by regulating essential processes such as keratinocyte (KC) proliferation, terminal differentiation, programmed cell death (apoptosis), and cornification. Furthermore, reduced SLURP1 expression has been linked to the pathogenesis of various epithelial cancers, suggesting its broader significance in maintaining epithelial tissue integrity and suppressing tumors. The management of Mal de Meleda remains a clinical challenge, as current therapeutic approaches are largely limited to alleviating symptoms rather than addressing the underlying cause. Systemic retinoids, particularly acitretin, have demonstrated efficacy in reducing epidermal hyperkeratosis and enhancing clinical outcomes. Nonetheless, prolonged administration may lead to significant side effects, necessitating close clinical supervision. This case report contributes to the medical literature by documenting a rare presentation of Mal de Meleda, highlighting the importance of recognizing atypical clinical features and implementing accurate diagnostic and therapeutic interventions. Psoriasis is a chronic, immune-mediated inflammatory dermatosis that exerts a profound effect on patients\u2019 quality of life. The disease typically follows a relapsing-remitting course and is frequently associated with a spectrum of comorbid conditions. In pediatric populations, the etiology of psoriasis is multifactorial, involving a combination of genetic susceptibility, environmental triggers, psychosocial stressors, obesity, physical trauma, cutaneous irritation, and exposure to certain pharmacological agents such as lithium, \u03b2-blockers, and tumor necrosis factor (TNF) inhibitors. Moreover, systemic inflammatory disorders like Crohn\u2019s disease and juvenile idiopathic arthritis have been linked to an increased risk of psoriasis in children. The disease burden is considerable in adults, but poses even greater challenges in pediatric patients, where atypical clinical presentations may hinder timely and accurate diagnosis. It is essential for dermatologists to accurately differentiate Mal de Meleda (MDM) from psoriasis, as these conditions may exhibit overlapping clinical features yet diverge significantly in therapeutic response and long-term prognosis. Distinctive diagnostic clues\u2014such as very early disease onset, autosomal recessive mode of inheritance, and the hallmark transgradient pattern of palmoplantar keratoderma\u2014can aid in distinguishing MDM from the more prevalent psoriasis vulgaris. Although biologic therapies targeting TNF-\u03b1 and IL-17A have shown limited efficacy in MDM, systemic retinoids continue to represent a clinically effective therapeutic option for managing this rare genodermatosis.<\/jats:p>","DOI":"10.3389\/fmed.2025.1634843","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T16:50:01Z","timestamp":1758214201000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Atypical manifestation of psoriasis in the elderly: possible expression of Mal de Meleda diagnosis review and case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Cristian","family":"Onisor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Maria","family":"Sarpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Niculet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40257-015-0157-1","article-title":"Mal de Meleda: a focused review.","volume":"17","author":"Perez","year":"2016","journal-title":"Am J Clin Dermatol."},{"key":"B2","year":"2023"},{"key":"B3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4103\/idoj.IDOJ_367_18","article-title":"Hereditary palmoplantar keratoderma: a practical approach to the diagnosis.","volume":"10","author":"Dev","year":"2019","journal-title":"Indian Dermatol Online J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/hmg\/10.8.875","article-title":"Mutations in the gene encoding SLURP-1 in Mal de Meleda.","volume":"10","author":"Fischer","year":"2001","journal-title":"Hum Mol Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.0022-202X.2005.23973.x","article-title":"Biological effects of SLURP-1 on human keratinocytes.","volume":"125","author":"Arredondo","year":"2005","journal-title":"J Invest Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/jid.2014.19","article-title":"Palmoplantar keratoderma along with neuromuscular and metabolic phenotypes in Slurp1-deficient mice.","volume":"134","author":"Adeyo","year":"2014","journal-title":"J Invest Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.clindermatol.2007.08.009","article-title":"Childhood psoriasis.","volume":"25","author":"Benoit","year":"2007","journal-title":"Clin Dermatol."},{"key":"B8","year":"2019","journal-title":"\u201cMeleda Disease\u201d."},{"key":"B9","year":"2019","journal-title":"Diagnosis: Mal de Meleda | The Dermatologist."},{"key":"B10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jaad.2009.07.029","article-title":"Incidence of psoriasis in children: a population-based study.","volume":"62","author":"Tollefson","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/archderm.141.12.1537","article-title":"Prevalence and treatment of psoriasis in the United Kingdom: a population-based study.","volume":"141","author":"Gelfand","year":"2005","journal-title":"Arch Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.12865\/CHSJ.42.01.14","article-title":"Psoriasis vulgaris in children \u2014 case presentation.","volume":"42","author":"Singer","year":"2016"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17nr02247","DOI":"10.4088\/PCC.17nr02247","article-title":"Psychiatric and psychological impact of chronic skin disease.","volume":"20","author":"Jafferany","year":"2018","journal-title":"Prim Care Companion CNS Disord."},{"key":"B14","first-page":"361","article-title":"Depression and suicidality in psoriasis and clinical studies of brodalumab: a narrative review.","volume":"104","author":"Koo","year":"2019","journal-title":"Cutis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.26574\/maedica.2019.14.3.287","article-title":"Psychological stress and depression in psoriasis patients - a dermatologist\u2019s perspective.","volume":"14","author":"Rigas","year":"2019","journal-title":"Maedica."},{"key":"B16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jaad.2005.10.008","article-title":"Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective.","volume":"54","author":"Mease","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1046\/j.1365-2133.2000.03829.x","article-title":"The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis.","volume":"143","author":"Yosipovitch","year":"2000","journal-title":"Br J Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/s0190-9622(97)80214-9","article-title":"The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort.","volume":"36","author":"McKenna","year":"1997","journal-title":"J Am Acad Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s11136-021-02991-2","article-title":"Happiness and depression in psoriasis: a cross-sectional study in Germany.","volume":"31","author":"Schuster","year":"2022","journal-title":"Qual Life Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2340\/00015555-0764","article-title":"Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics.","volume":"90","author":"Ljosaa","year":"2010","journal-title":"Acta Derm Venereol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/j.jsxm.2019.08.017","article-title":"Psychological and sexual consequences of psoriasis vulgaris on patients and their partners.","volume":"16","author":"Alariny","year":"2019","journal-title":"J Sex Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"100565","DOI":"10.1016\/j.bbih.2022.100565","article-title":"Brain structure and connectivity in psoriasis and associations with depression and inflammation; findings from the UK biobank.","volume":"26","author":"Lada","year":"2022","journal-title":"Brain Behav Immun Health."},{"key":"B23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.36131\/cnfioritieditore20200402","article-title":"Psychosomatic syndromes and symptom severity in chronic psoriasis.","volume":"17","author":"Petito","year":"2020","journal-title":"Clin Neuropsychiatry."},{"key":"B24","doi-asserted-by":"publisher","first-page":"110347","DOI":"10.1016\/j.jpsychores.2020.110347","article-title":"Suicidal risks with psoriasis and atopic dermatitis: systematic review and meta-analysis.","volume":"141","author":"Pompili","year":"2021","journal-title":"J Psychosom Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"adv3962","DOI":"10.2340\/actadv.v103.3962","article-title":"Comparative analysis of the predictors, extent and impacts of self-stigma in patients with psoriasis and atopic dermatitis.","volume":"103","author":"Schlachter","year":"2023","journal-title":"Acta Derm Venereol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.euroneuro.2014.04.004","article-title":"Duloxetine-bupropion combination for treatment-resistant atypical depression: a double-blind, randomized, placebo-controlled trial.","volume":"24","author":"Fornaro","year":"2014","journal-title":"Eur Neuropsychopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/pde.15185","article-title":"Manifestation of anxiety and depression among pediatric patients with psoriasis: a review.","volume":"40","author":"Strouphauer","year":"2023","journal-title":"Pediatr Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"adv00769","DOI":"10.2340\/actadv.v102.1386","article-title":"Prevalence and odds of anxiety disorders and anxiety symptoms in children and adults with psoriasis: systematic review and meta-analysis.","volume":"102","author":"Jalenques","year":"2022","journal-title":"Acta Derm Venereol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/ced.14218","article-title":"Sex- and gender-associated clinical and psychosocial characteristics of patients with psoriasis.","volume":"45","author":"Napolitano","year":"2020","journal-title":"Clin Exp Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence.","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.anplas.2008.08.003","article-title":"[Surgical treatment of keratosis palmaris in Mal de Meleda].","volume":"54","author":"Marchac","year":"2009","journal-title":"Ann Chir Plast Esthet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e8881","DOI":"10.1002\/ccr3.8881","article-title":"Hereditary epidermolytic palmoplantar keratosis due to a novel desmoglein-1 mutation: a case report.","volume":"12","author":"Koschitzki","year":"2024","journal-title":"Clin Case Rep."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1634843\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T16:50:02Z","timestamp":1758214202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1634843\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":32,"alternative-id":["10.3389\/fmed.2025.1634843"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1634843","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"article-number":"1634843"}}